Pronađeno: 1-10 / 29 radova

Autori: Tomasevic Zorica I

>> Prikaži sve rezultate

Naslov Overall survival with neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): A randomised, double-blind, placebo-controlled, phase 3 trial (Article)
Autori Holmes Frankie A  ...  Tomasevic Zorica I  ...  (broj koautora 27) 
Info EUROPEAN JOURNAL OF CANCER, (2023), vol. 184 br. , str. 48-59
Projekat Puma Biotechnology Inc
Ispravka ISI/Web of Science   Članak   Elečas   Rang časopisa   Citati:
Naslov White blood cell subsets in HER2-positive breast cancer patients treated with trastuzumab in relation to clinical outcome (Article)
Autori Matic Ivana Z  Grujic Milica  Kolundzija Branka S  Damjanovic Ana B  Tomasevic Zorica I  Djordjic-Crnogorac Marija J  Dzodic Radan R  Filipovic-Ljeskovic Ivana M  Zdrale Zdravko  Eric-Nikolic Aleksandra M  Juranic Zorica D 
Info PATHOLOGY RESEARCH AND PRACTICE, (2021), vol. 224 br. , str. -
Projekat Ministry of Education, Science and Technological Development, Serbia [451039/202114/200043]
Ispravka ISI/Web of Science   Članak   Elečas   Rang časopisa   Citati: ISI/Web of Science   Scopus  
Naslov The impact of structured education of breast cancer patients receiving capecitabine on mental disorders (Article)
Autori Tadic Dusanka Lj  Djukic-Dejanovic Slavica M  Tomasevic Zorica I  Djokovic Danijela  Janjic Vladimir S 
Info JOURNAL OF BUON, (2020), vol. 25 br. 1, str. 141-151
Ispravka ISI/Web of Science   Elečas   Rang časopisa   Citati: ISI/Web of Science   Scopus  
Naslov Cardiac Safety of the Trastuzumab Biosimilar ABP 980 in Women with HER2-Positive Early Breast Cancer in the Randomized, Double-Blind, Active-Controlled LILAC Study (Article)
Autori Kolberg Hans-Christian  Colleoni Marco A  Demetriou Georgia Savva  Santi Patricia Xavier  Tesch Hans  Fujiwara Yasuhiro  Tomasevic Zorica I  Hanes Vladimir 
Info DRUG SAFETY, (2020), vol. 43 br. 3, str. 233-242
Ispravka ISI/Web of Science   Članak   Elečas   Rang časopisa   Citati: ISI/Web of Science   Scopus  
Naslov AROME-ESO Oncology Consensus Conference: access to cancer care innovations in countries with limited resources. Association of Radiotherapy and Oncology of the Mediterranean Area (AROME-Paris) and European School of Oncology (ESO - Milan) (Article)
Autori Todorovic Vladimir  ...  Babovic Nada Lj  ...  Cetnikovic Bojana  Ceric Timur  ...  Dzamic Zoran M  Dzodic Radan R  Eri Zivka  ...  Knezevic-Usaj Slavica F  Kovcin Vladimir N  ...  Markovic Ivan Z  Markovic Milan  Mijalkovic Nenad  ...  Pantelic Aleksandra  Popovic Lazar S  Radosavljevic Davorin Z  ...  Radulovic Sinisa S  ...  Rosic Ivana  ...  Stamatovic Ljiljana  ...  Tesanovic Dusanka D  Tomasevic Zorica I  Tomasevic Zoran M  ...  Vasovic Suzana  Vicko Ferenc  ...  Zaric Bojan  ...  (broj koautora 65) 
Info JOURNAL OF BUON, (2019), vol. 24 br. 5, str. 2180-2197
Ispravka ISI/Web of Science   Elečas   Rang časopisa   Citati: ISI/Web of Science   Scopus  
Naslov Germline mutations in cancer susceptibility genes in high grade serous ovarian cancer in Serbia (Article)
Autori Krivokuca Ana M  Boljevic Ivana Z  Jovandic Stevo  Magic Zvonko M  Mandic Aljosa D  Tomasevic Zorica I  Brankovic-Magic Mirjana V 
Info JOURNAL OF HUMAN GENETICS, (2019), vol. 64 br. 4, str. 281-290
Projekat Ministry of Education, Science and Technological development of the Republic of Serbia [41026]
Ispravka ISI/Web of Science   Članak   Elečas   Rang časopisa   Citati: ISI/Web of Science   Scopus  
Naslov PIK3CA alterations and benefit with neratinib: analysis from the randomized, double-blind, placebo-controlled, phase III ExteNET trial (Article)
Autori Chia Stephen KL  ...  Tomasevic Zorica I  ...  (broj koautora 26) 
Info BREAST CANCER RESEARCH, (2019), vol. 21 br. , str. -
Projekat Wyeth; Pfizer; Puma Biotechnology; Puma Biotechnology Inc.
Ispravka ISI/Web of Science   Članak   Elečas   Rang časopisa   Citati: ISI/Web of Science   Scopus  
Naslov Expenditures on Oncology Drugs and Cancer Mortality-to-Incidence Ratio in Central and Eastern Europe (Article)
Autori Vrdoljak Eduard  ...  Tomasevic Zorica I  ...  (broj koautora 16) 
Info ONCOLOGIST, (2019), vol. 24 br. 1, str. E30-E37
Projekat Roche
Ispravka ISI/Web of Science   Članak   Elečas   Rang časopisa   Citati: ISI/Web of Science   Scopus  
Naslov Efficacy and safety of ABP 980 compared with reference trastuzumab in women with HER2-positive early breast cancer (LILAC study): a randomised, double-blind, phase 3 trial (Article)
Autori von Minckwitz Gunter  Colleoni Marco A  Kolberg Hans-Christian  Morales Serafin  Santi Patricia Xavier  Tomasevic Zorica I  Zhang Nan  Hanes Vladimir 
Info LANCET ONCOLOGY, (2018), vol. 19 br. 7, str. 987-998
Projekat Amgen
Ispravka ISI/Web of Science   Članak   Elečas   Rang časopisa   Citati: ISI/Web of Science   Scopus  
Ispis zapisa u formatu:TXT | BibTeX